UNSW Embryology

DEVELOPMENT OF THE GASTROINTESTINAL SYSTEM

Embryology Home Page

HIRSCHSPRUNG DISEASE 2

Select Entry from OMIM

Online Mendelian Inheritance in Man (Internet Link)

This page is for computers without external internet access.

Back to UNSW Embryology-Gastrointestinal Notes

List of OMIM search results "hirschsprung"

#600155 HIRSCHSPRUNG DISEASE 2; HSCR2

table OF CONTENTS

Database Links

Gene Map Locus: 13q22
Note: pressing the symbol will find the citations in MEDLINE whose text most closely matches the text of the preceding OMIM paragraph, using the Entrez MEDLINE neighboring function.

 

TEXT

A number sign (#) is used with this entry because of evidence that the mutation resides in the gene encoding the endothelin B receptor (EDNRB; 131244).

Hirschsprung disease (HSCR; 142623), or aganglionic megacolon, is a congenital disorder characterized by absence of enteric ganglia along a variable length of the intestine. Dominant mutations in the RET oncogene (164761) can give rise to the disorder; see 164761.0014. There is also evidence for a recessive gene on chromosome 13 as a cause of this disorder. Tentatively, the Hirschsprung disease related to chromosome 13 will be referred to here as Hirschsprung disease-2 (HSCR2). See also HSCR3 (600156), a putative chromosome 21-linked HSCR modifier locus.

Puffenberger et al. (1992) found a high frequency of Hirschsprung disease in an extended inbred Mennonite kindred. In 49 nuclear families, 56 affected persons were found. In one of these individuals, one or more of the following characteristics was found: white forelock, hearing deficit, and heterochromia iridis. However, further studies suggested that this triad of traits segregated independently of Hirschsprung disease in several of the families within the kindred. A couple who immigrated to the United States about 1717 was ancestral to both parents of all affected individuals. Segregation analysis yielded a segregation ratio of 12.0% for males and 6.2% for females.

Lamont et al. (1989) described 3 cases of interstitial deletion of chromosome 13 involving the common segment 13q22.1-q32.1. In addition to the recognized clinical features of this deletion, such as prominent upper incisors, 2 had short segment Hirschsprung disease with aganglionosis confirmed histologically. Bottani et al. (1991) also described an interstitial deletion of 13q in approximately the same region in a boy who, in addition to having Hirschsprung disease, was mentally retarded and autistic. They concluded that the 13q33.1 band was missing in all cells. Sparkes et al. (1984) and Kiss and Osztovics (1989) had also reported Hirschsprung disease in association with deletions of 13q.

In further studies of the large and extensively affected Mennonite kindred, Puffenberger et al. (1994) found that segregation analysis indicated a segregation ratio of 10.67% for males and 5.45% for females. They searched for locations of the genes responsible for HSCR in this kindred by genotyping 3 small multicase families and locating genomic regions demonstrating identity-by-descent followed by linkage disequilibrium analysis of 28 additional nuclear families. Based on this novel strategy, Puffenberger et al. (1994) identified a new locus for HSCR on 13q22. They genotyped 9 microsatellite markers spanning 10 cM in this region on 31 nuclear families. Significant nonrandom association was detected with alleles at 4 markers. In addition, their studies in this kindred revealed preliminary evidence for a genetic modifier of HSCR located on 21q22 (600156).

Cohen and Gadd (1982) had suggested a dominant inheritance pattern for HSCR in the Mennonite kindred. However, arguing against this was the high degree of inbreeding and the identification of a single common ancestral couple for all 122 parents. In the series of 61 nuclear families, only 3 contained a parent with documented HSCR. Although this disorder was effectively lethal 1 or 2 generations ago, some affected persons had undergone surgical treatment, survived to adulthood, and reproduced. A total of 13 affected parents had a total of 6 affected and 52 unaffected offspring (segregation ratio, 10.3%). These data were considered consistent with a recessive mode of inheritance with a relatively high carrier frequency in this population (Puffenberger et al., 1994). If the susceptibility gene on chromosome 13 is recessive, then the segregation analysis suggests that penetrance is about 32%. Puffenberger et al. (1994) reported association studies indicating that 36% of homozygotes for a 235-basepair allele at locus D13S160 were affected and 27% of heterozygotes were affected, giving an overall penetrance of 31%, which accords well with the 33% value estimated by Badner et al. (1990). In studies of 2 patients with HSCR and interstitial deletions of chromosome 13 analyzed with microsatellite markers, they found that the 13q22 region was included and was bounded distally by D13S160.

Badner et al. (1990) suggested that recessive inheritance might account for up to 80% of cases of Hirschsprung disease.

As detailed in entry 131244, Puffenberger et al. (1994) studied the endothelin-B receptor gene which maps to the same area of chromosome 13 as does the Mennonite Hirschsprung disease and found point mutations.

The locus in the mouse that is homologous to the chromosome 13 locus for Hirschsprung disease in the human may be 'piebald lethal' (s-l), which is located on chromosome 14; this chromosome in the mouse carries several other loci that are homologous to chromosome 13 loci.


SEE ALSO

Puffenberger et al. (1994)

 

REFERENCES

1. Badner, J. A.; Sieber, W. K.; Garver, K. L.; Chakravarti, A. :
A genetic study of Hirschsprung disease. Am. J. Hum. Genet. 46: 568-580, 1990.
PubMed ID : 2309705
2. Bottani, A.; Xie, Y.; Binkert, F.; Schinzel, A. :
A case of Hirschsprung disease with a chromosome 13 microdeletion, del(13)(q32.3q33.2): potential mapping of one disease locus. Hum. Genet. 87: 748-750, 1991.
PubMed ID : 1937482
3. Cohen, I. T.; Gadd, M. A. :
Hirschsprung's disease in a kindred : a possible clue to the genetics of the disease. J. Pediat. Surg. 17: 632-634, 1982.
PubMed ID : 6217309
4. Kiss, P.; Osztovics, M. :
Association of 13q deletion and Hirschsprung's disease. J. Med. Genet. 26: 793-794, 1989.
PubMed ID : 2614805
5. Lamont, M. A.; Fitchett, M.; Dennis, N. R. :
Interstitial deletion of distal 13q associated with Hirschsprung's disease. J. Med. Genet. 26: 100-104, 1989.
PubMed ID : 2918536
6. Puffenberger, E. G.; Hosoda, K.; Washington, S. S.; Nakao, K.; deWit, D.; Yanagisawa, M.; Chakravarti, A. :
A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79: 1257-1266, 1994.
PubMed ID : 8001158
7. Puffenberger, E. G.; Kauffman, E. R.; Bolk, S.; Matise, T. C.; Washington, S. S.; Angrist, M.; Weissenbach, J.; Garver, K. L.; Mascari, M.; Ladda, R.; Slaugenhaupt, S. A.; Chakravarti, A. :
Identity-by-descent and association mapping of a recessive gene for Hirschsprung disease on human chromosome 13q22. Hum. Molec. Genet. 3: 1217-1225, 1994.
PubMed ID : 7987295
8. Puffenberger, E. G.; Kompanek, A. J.; Kauffman, E. R.; Mascari, M.; Ladda, R.; Chakravarti, A. :
Pedigree analysis of a large Mennonite kindred segregating Hirschsprung disease. (Abstract) Am. J. Hum. Genet. 51 (suppl.): A106, 1992.
9. Puffenberger, E. G.; Washington, S. S.; Cass, D.; Chakravarti, A. :
Mapping studies of Hirschsprung disease on chromosome 13q22. (Abstract) Am. J. Hum. Genet. 55 (suppl.): A4, 1994.

 

10. Sparkes, R. S.; Sparkes, M. C.; Kalina, R. E.; Pagon, R. A.; Salk, D. J.; Disteche, C. M. :
Separation of retinoblastoma and esterase D loci in a patient with sporadic retinoblastoma and del(13)(q14.1q22.3). Hum. Genet. 68: 258-259, 1984.
PubMed ID : 6500578

 

CLINICAL SYNOPSIS

View Clinical Synopsis Entry

 

CREATION DATE

Victor A. McKusick : 10/19/1994

EDIT HISTORY

dkim : 7/2/1998
mark : 10/8/1997
joanna : 2/1/1996
mimadm : 9/23/1995
mark : 6/6/1995
mark : 5/2/1995
carol : 1/26/1995

Back to UNSW Embryology-Gastrointestinal Notes


m.hill@unsw.edu.au
Date Last Modified: 11/3/99
This site maintained by Dr M. Hill